WebApr 11, 2024 · These data could explain, at the same time, the two main findings described above: increased apoptosis and lower resistance to anti-MM drugs (protective role mediated by IRF4, MYC, IKZF1/3), and... WebNov 5, 2024 · IRF4 was identified to be enriched in regions of accessible chromatin upon BCL7A loss. IRF4 is an oncoprotein transcription factor and is a direct target of myc, generating a feedback loop in MM cells. IRF4 dependency is central to myeloma cell proliferation. Most importantly, we found that in addition to functions within the m …
The homeobox transcription factor MEIS2 is a regulator of cancer …
WebJun 1, 2024 · Proteolytic targeting chimera (PROTAC) technology, a novel protein blocking technology based on the ubiquitination‒proteasome system (UPS) to target and induce … WebDec 1, 2016 · In this context, IRF4, a critical regulator of the normal adaptive immune response, plays a major role in MM progression; indeed, interference with IRF4 expression … simple ways to make a living
Proteolysis targeting chimera - Wikipedia
WebCRISPR knockout of IRF4 attenuated c-Myc levels and increased sensitivity to a BET protein inhibitor. Co-treatment with BET inhibitor or BET-PROTAC and ibrutinib or venetoclax exerted synergistic in vitro lethality in the RT-DLBCL cells. Finally, as compared to each agent alone, combination therapy with BET-PROTAC and venetoclax significantly ... WebMar 18, 2024 · To see how PROTAC concentration affects the rate of degradation, we plotted the same data in reverse, tracking the decrease in BRD4 protein over time to calculate the time that is required to degrade 50% of BRD4 protein (T50%) for each concentration of MZ1. From these plots, we observed that T50% decreased with … WebMar 7, 2024 · Pro-apoptotic BAX is the critical effector of mitochondrial apoptosis induced by most BH3 mimetics and chemotherapeutic agents 25, 30, 31, 32. Typically, upon pro … raylass dept store